Drug Profile
KFA 1982
Alternative Names: Factor Xa inhibitor - Kissei; KFA 1829Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Deep vein thrombosis; Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Deep-vein-thrombosis in Europe (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Thrombosis in Europe (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Thrombosis in Japan (PO)